Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Aug 13, 2014
    Warning Letter Blasts Raw Foods Company Over Drug-like Claims
  • Aug 8, 2014
    CMS Pauses Open Payment Access After Doctor Gets Erroneous Pay Data
  • Aug 7, 2014
    Pfizer To Pay States $35 Million To Settle Off-label Allegations
  • Aug 6, 2014
    Medical Societies Press CMS for Delay in Open Payments Reporting
  • Jul 31, 2014
    Medical Associations, Trade Groups Press CMS To Improve Open Payments System
  • Jul 23, 2014
    FDA Study on How Teens Process Risk Information Goes to OMB
  • Jul 21, 2014
    Three States Sue Makers of 5-hour Energy, Alleging Use of Deceptive Ads and Misleading Claims
  • Jul 18, 2014
    Telemarketing Script Draws Untitled Letter From OPDP Over Missing Risk Information
  • Jul 15, 2014
    OPDP Apologizes for Webinar Glitches, Offers Slides and Q&A for Those Who Missed It
  • Jul 14, 2014
    FDA Letter: ‘Liking’ Consumer Testimonials on Facebook Constitutes an Endorsement
  • More

Good Clinical Practice

  • Apr 15, 2016
    INC Research, CISCRP To Work on Public Awareness of Clinical Trials
  • Apr 13, 2016
    Biopharma Firm Resolves SEC Charges That It Misled Investors About New Drug’s Standing With FDA
  • Apr 13, 2016
    Study Finds Most Protocol Amendments Are Avoidable
  • Apr 13, 2016
    N.Y. Bill Allows Release of Confidential HIV-related Information for Research
  • Apr 13, 2016
    FDA BIMO Inspections Nearly Constant in FY 2015
  • Apr 9, 2016
    Senate Considers Bill To Improve the Inclusion of Minorities and Women in NIH Research
  • Apr 4, 2016
    FDA Issues Direct Rule Clarifying Sanctions the Agency Can Take Against IRB Non-compliance
  • Apr 4, 2016
    Senate Bill Looks To Reduce NIH ‘Paperwork’ Burden
  • Apr 4, 2016
    Lack of CoI Understanding Found in Maryland Review of Industrial Partnership Research Project
  • Mar 29, 2016
    Georgia ‘Right-to-Try’ Bill Sent to Governor
  • More

FDA Regulation & Enforcement

  • Jan 8, 2019
    Georgia Files Lawsuit Against Opioid Makers
  • Jan 4, 2019
    Advertising Groups Contend DTC Pricing Proposal Will Not Satisfy Constitutional Scrutiny
  • Jan 3, 2019
    AMS Publishes Bioengineered Food Disclosure Standard
  • Jan 3, 2019
    TGA Answers Questions on 2019 Ad Code
  • Dec 22, 2018
    Connecticut Files Suit Against Purdue Pharma, 15 Company Officials Over Opioid Marketing
  • Dec 22, 2018
    Judge Allows National Opioid Case To Continue
  • Dec 21, 2018
    Former Owner, Employees of New England Compounding Center Convicted of Multiple Crimes
  • Dec 21, 2018
    Company Discontinues Supplement Claims After NAD Inquiry
  • Dec 21, 2018
    FDA Issues Technical Amendments to Facts Panel Revisions
  • Dec 19, 2018
    ABPI Revises Code of Practice
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.